<DOC>
	<DOC>NCT00796809</DOC>
	<brief_summary>The goal of the project is to study the risk of coccidioidomycosis (valley fever) in patients receiving anti-TNF and other biologic agents for inflammatory arthritis in Tucson, Arizona.</brief_summary>
	<brief_title>Risk of Coccidioidomycosis in Patients Receiving Anti-TNF and Other Biologic Agents for an Inflammatory Arthritis</brief_title>
	<detailed_description>Retrospective chart review of all patients with an inflammatory arthritis seen at the University Rheumatology clinic since January 2000.</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Coccidioidomycosis</mesh_term>
	<mesh_term>Coccidiosis</mesh_term>
	<criteria>All active patients with an inflammatory arthritis seen at the University of Arizona from January 2000</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>TNF inhibitors</keyword>
	<keyword>Biologic agents</keyword>
	<keyword>coccidioidomycosis</keyword>
	<keyword>Rheumatoid arthritis</keyword>
</DOC>